Genotypes and phenotypes of patients with Lafora disease living in Germany.
David BrennerTobias BaumgartnerSarah von SpiczakJan LewerenzRoger WeisAnja GrimmerPetra GaspirovaClaudia D WursterWolfram S KunzJan WagnerBerge A MinassianChristian E ElgerAlbert C LudolphSaskia BiskupDennis DöckerPublished in: Neurological research and practice (2019)
This is the first larger case series of Lafora patients in Germany. Our data enable an approximation of the prevalence of manifest Lafora disease in Germany to 1,69 per 10 million people. Broader application of gene panel or whole-exome diagnostics helps clarifying unclassified progressive myoclonus epilepsy and establish an early diagnosis, which will be even more important as causal therapy approaches have been developed and are soon to be tested in a phase I study.